08.14.25 -- Unlocking Value In Biopharma Operations: A C-Suite Call To Action

Chief Scientific Officer Jon Lenn discusses the balance of art and science in topical formulation development, emphasizing advanced skin models for optimized delivery, activity, and product stability.

Explore the calculation of Overall Equipment Effectiveness (OEE) and the impact of product inspection equipment on OEE in the pharmaceutical industry.

PUPSIT and other integrity testing methods are crucial for manufacturers to reduce contamination risks and ensure drug product safety. Learn how your company can adhere to updated regulatory guidelines.

Gain guidance on the choice of formulation, excipients, and the micronization technologies offered by CDMOs, and learn about current encapsulation technologies for inhaled products.

Enhancing the solubility of poorly soluble APIs is vital for improving bioavailability. Discover how advanced formulation techniques like hot-melt extrusion and spray drying can overcome this challenge.

Watch how a nitrogen purge qualification study optimized an existing filling line by reducing headspace oxygen from 5% to 2% using real-time, non-destructive analysis for improved process control.

Companies still relying on paper-based manufacturing are falling behind. See how digital transformation boosts efficiency, reduces errors, and ensures compliance in this essential shift.

Pharmaceutical companies should leverage oral minitablets to extend drug lifecycles, optimize dosing, and improve patient-centric solutions while overcoming manufacturing challenges.

Delve into the growing interest in drug delivery methods that target the brain and central nervous system via absorption into the bloodstream, specifically focusing on crossing the blood-brain barrier (BBB).

Bovine collagen, valued for biocompatibility and versatility, is gaining attention for medical devices in China as regulatory barriers ease, though safety assurances remain crucial.

Read how life sciences solutions integrate advanced technologies and AI to accelerate drug discovery and streamline workflows for innovative biopharmaceutical research and development.

It is important to have clean laboratory equipment, as any “leftover” proteins could contaminate your next experiment. Examine three of the best methods for cleaning proteins, RNA, and DNA.

A mobile cleanroom facility was needed for manufacturing a new monoclonal antibody product for phase 1 clinical trials. The facility had to have the ability to be repurposed for additional applications.

Although well-established processes, spray drying and hot-melt extrusion can be outperformed in bioavailability, cost-savings, manufacturing speed, environmental impact, and more.